Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 14, Issue 12, Pages 1133-1142
Publisher
Informa UK Limited
Online
2013-09-18
DOI
10.4161/cbt.26170
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating microRNAs in cancer: origin, function and application
- (2012) Ruimin Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
- (2012) Na Liu et al. LANCET ONCOLOGY
- Small RNAs have a large impact
- (2012) Matthew Weiland et al. RNA Biology
- Application study of the 2008 staging system of nasopharyngeal carcinoma
- (2012) Zhi-Xiong Lin et al. Chinese Journal of Cancer
- A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma
- (2012) Yan-Ping Mao et al. Chinese Journal of Cancer
- Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs
- (2011) Alissa Michelle Go Wong et al. CANCER
- Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
- (2011) Jian Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
- (2010) Nobuyoshi Kosaka et al. CANCER SCIENCE
- MicroRNA-21: From Cancer to Cardiovascular Disease
- (2010) Virginija Jazbutyte et al. CURRENT DRUG TARGETS
- Flow cytometric analysis of circulating microparticles in plasma
- (2010) Aaron F. Orozco et al. CYTOMETRY PART A
- Implication of microRNAs in drug resistance for designing novel cancer therapy
- (2010) Fazlul H. Sarkar et al. DRUG RESISTANCE UPDATES
- Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature
- (2010) Nathalie Schöler et al. EXPERIMENTAL HEMATOLOGY
- Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers
- (2010) Lei Yu et al. INTERNATIONAL JOURNAL OF CANCER
- miRBase: integrating microRNA annotation and deep-sequencing data
- (2010) A. Kozomara et al. NUCLEIC ACIDS RESEARCH
- miR-24 up-regulation in oral carcinoma: Positive association from clinical and in vitro analysis
- (2010) Shu-Chun Lin et al. ORAL ONCOLOGY
- MicroRNAs in Human Embryonic and Cancer Stem Cells
- (2010) Alfons Navarro et al. YONSEI MEDICAL JOURNAL
- MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
- (2009) H-C Chen et al. BRITISH JOURNAL OF CANCER
- The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types
- (2008) AS Abdulamir et al. BMC PUBLIC HEALTH
- Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
- (2008) Charles H. Lawrie et al. BRITISH JOURNAL OF HAEMATOLOGY
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- miR-21: a small multi-faceted RNA
- (2008) Anna M. Krichevsky et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma
- (2008) K. Cosmopoulos et al. JOURNAL OF VIROLOGY
- Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
- (2008) Noam Stern-Ginossar et al. NATURE IMMUNOLOGY
- Detection of microRNA Expression in Human Peripheral Blood Microvesicles
- (2008) Melissa Piper Hunter et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now